Abstract
The present study aims to view new treatment strategies based on a special metabolic pathway for the cancer, looking for another breakthrough in medical treatment, and also it the aim is that as a further benefit, it may also assist allay some of the human resource lines engendered by chronic disease. Definitely, the present study assess what kinds of metabolic differences are occurring during cancer development, detect the metabolic features of particular cancers, then see how the new metabolic therapies are working on patient results. Through connecting and classifying difference kinds of basic materials from different cancers, this research hopes to find out major goals for therapy.
Method: 240 cancer cell samples were done with metabolic profiling by using advanced techniques such as mass spectrometry and nuclear magnetic resonance spectroscopy. Such sophisticated methods were further supported by modern data analysis capabilities like machine learning to prove exactly what metabolic patterns are unique to each particular cancer type.
Results: The present study has found different metabolic signatures referred to the various phenotypes in cancerous cells, shown by alterations in lactate, glutamate, and alanine levels. Thus, cancer from normal cells can be distinguished by machine learning models, underlining this particular way in which metabolism is important for diagnostics and treatment of cancer. Furthermore, in the molecular experiments, it was possible to find an effective inhibition of growth in cancer cells which can be completed; thus, such target-specific metabolic pathways also need more research work to be done because it is not fully understood.
Conclusion: The designation metabolic features of cancer cells form a platform upon new strategies to cancer treatment can be really developed. Metabolite profiling will assist the detect biochemical aspect to transform it into clinical practice, consequently this research could be a landmark advance in cancer. Further metabolite profiling study may assist for various cancer subordinate type and integrating the novel omics information being developed of good, personalized therapies.
Method: 240 cancer cell samples were done with metabolic profiling by using advanced techniques such as mass spectrometry and nuclear magnetic resonance spectroscopy. Such sophisticated methods were further supported by modern data analysis capabilities like machine learning to prove exactly what metabolic patterns are unique to each particular cancer type.
Results: The present study has found different metabolic signatures referred to the various phenotypes in cancerous cells, shown by alterations in lactate, glutamate, and alanine levels. Thus, cancer from normal cells can be distinguished by machine learning models, underlining this particular way in which metabolism is important for diagnostics and treatment of cancer. Furthermore, in the molecular experiments, it was possible to find an effective inhibition of growth in cancer cells which can be completed; thus, such target-specific metabolic pathways also need more research work to be done because it is not fully understood.
Conclusion: The designation metabolic features of cancer cells form a platform upon new strategies to cancer treatment can be really developed. Metabolite profiling will assist the detect biochemical aspect to transform it into clinical practice, consequently this research could be a landmark advance in cancer. Further metabolite profiling study may assist for various cancer subordinate type and integrating the novel omics information being developed of good, personalized therapies.
Keywords
cancer; metabolism; metabolic pathway; therapeutic strategies; machine learning.